S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
S&P 500   3,783.28 (-0.20%)
DOW   30,273.87 (-0.14%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)

Avenue Therapeutics - ATXI Institutional Ownership

$8.47
-6.03 (-41.59%)
(As of 10/5/2022 05:11 PM ET)
Add
Compare
Today's Range
$8.12
$10.50
50-Day Range
$3.21
$67.50
52-Week Range
$3.00
$27.75
Volume
2.70 million shs
Average Volume
874,486 shs
Market Capitalization
$12.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Institutional Ownership Changes (13F Filings) for Avenue Therapeutics (NASDAQ:ATXI)

Current
Institutional Ownership
Percentage
10.87%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$1.42 M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$1.07 M
Skip Chart & View Institutional Buying and Selling Data

ATXI Institutional Buying and Selling by Quarter

Get ATXI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avenue Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Avenue Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Renaissance Technologies LLC124,400$34K0.0%N/A0.572%
5/17/2022Virtu Financial LLC58,004$28K0.0%N/A0.267%
1/28/2022National Asset Management Inc.71,338$65K0.0%-20.1%0.376%
11/16/2021National Asset Management Inc.89,237$0.13M0.0%-29.2%0.531%
10/19/2021Kestra Advisory Services LLC22,500$34K0.0%N/A0.134%
9/17/2021Virtu Financial LLC26,373$66K0.0%N/A0.157%
9/3/2021Parametric Portfolio Associates LLC10,554$26K0.0%-59.2%0.063%
8/16/2021Occudo Quantitative Strategies LP14,398$36K0.0%N/A0.086%
8/13/2021Renaissance Technologies LLC78,314$0.20M0.0%N/A0.468%
8/13/2021Northern Trust Corp13,767$35K0.0%-82.1%0.082%
8/13/2021Geode Capital Management LLC79,556$0.20M0.0%-40.0%0.475%
8/13/2021Vanguard Group Inc.449,982$1.13M0.0%-35.5%2.687%
8/12/2021XTX Topco Ltd10,864$27K0.0%N/A0.065%
8/12/2021Advisory Services Network LLC35,121$88K0.0%N/A0.210%
8/12/2021Ergoteles LLC30,400$76K0.0%N/A0.182%
8/10/2021National Asset Management Inc.126,037$0.32M0.0%-26.1%0.753%
5/20/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060%
5/19/2021Squarepoint Ops LLC11,668$71K0.0%N/A0.070%
5/17/2021Goldman Sachs Group Inc.17,319$0.11M0.0%N/A0.103%
5/13/2021Trexquant Investment LP13,874$84K0.0%N/A0.083%
5/13/2021Axiom Investment Management LLC10,000$60K0.0%N/A0.060%
5/13/2021Barclays PLC5,568$34K0.0%+159.0%0.033%
5/12/2021Northern Trust Corp77,049$0.47M0.0%-6.8%0.460%
5/12/2021Geode Capital Management LLC132,594$0.80M0.0%+5.9%0.792%
2/24/2021Virtu Financial LLC17,469$0.10M0.0%N/A0.104%
2/19/2021JPMorgan Chase & Co.17,102$0.10M0.0%+260.2%0.102%
2/17/2021Jane Street Group LLC13,288$79K0.0%N/A0.079%
2/11/2021Northern Trust Corp82,691$0.49M0.0%+2.1%0.494%
2/9/2021Wells Fargo & Company MN16,406$98K0.0%-13.2%0.098%
2/5/2021BlackRock Inc.361,486$2.15M0.0%+5.5%2.158%
2/4/2021National Asset Management Inc.167,787$1M0.1%+15.0%1.002%
11/13/2020Morgan Stanley22,706$0.25M0.0%+270.9%0.136%
11/10/2020State Street Corp73,316$0.79M0.0%+9.5%0.438%
11/9/2020National Asset Management Inc.145,887$1.58M0.1%+42.7%0.871%
11/6/2020BlackRock Inc.342,742$3.71M0.0%+7.4%2.052%
10/20/2020Nisa Investment Advisors LLC19,069$0.21M0.0%N/A0.114%
8/25/2020Nuveen Asset Management LLC32,114$0.35M0.0%N/A0.192%
8/20/2020Charles Schwab Investment Management Inc.14,314$0.16M0.0%N/A0.086%
8/17/2020Jane Street Group LLC14,010$0.15M0.0%N/A0.084%
8/14/2020Bank of America Corp DE2,694$29K0.0%-62.0%0.016%
8/12/2020American International Group Inc.4,075$44K0.0%N/A0.024%
8/12/2020Bank of New York Mellon Corp15,032$0.16M0.0%N/A0.090%
8/7/2020New York State Common Retirement Fund9,000$97K0.0%N/A0.054%
7/31/2020National Asset Management Inc.102,200$1.10M0.1%+6.5%0.613%
7/31/2020UBS Group AG6,328$68K0.0%+216.4%0.038%
7/31/2020Mackay Shields LLC25,300$0.27M0.0%N/A0.152%
5/18/2020Advisor Group Holdings Inc.33,745$0.30M0.0%N/A0.202%
5/15/2020Squarepoint Ops LLC19,410$0.17M0.0%N/A0.116%
5/15/2020Morgan Stanley4,691$42K0.0%+47.3%0.028%
5/14/2020Geode Capital Management LLC70,115$0.63M0.0%+3.2%0.420%
5/9/2020National Asset Management Inc.96,000$0.86M0.1%+25.9%0.576%
5/1/2020BlackRock Inc.47,057$0.42M0.0%+7.9%0.282%
2/13/2020Renaissance Technologies LLC12,553$0.12M0.0%N/A0.075%
2/10/2020National Asset Management Inc.76,250$0.73M0.1%+3.4%0.458%
11/27/2019Squarepoint Ops LLC12,726$76K0.0%N/A0.076%
8/13/2019BlackRock Inc.39,933$0.25M0.0%+135.7%0.241%
8/5/2019National Asset Management Inc.64,750$0.41M0.0%+9.3%0.391%
5/8/2019National Asset Management Inc.59,250$0.28M0.0%-10.6%0.358%
5/7/2019Spark Investment Management LLC30,500$0.14M0.0%N/A0.184%
2/14/2019Opaleye Management Inc.496,000$2.68M1.0%N/A4.649%
2/12/2019Northern Trust Corp14,568$79K0.0%N/A0.137%
2/8/2019National Asset Management Inc.66,250$0.36M0.1%+4.7%0.621%
(Data available from 1/1/2016 forward)













ATXI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ATXI shares?

During the previous two years, 24 institutional investors and hedge funds held shares of Avenue Therapeutics. The most heavily invested institutionals were BlackRock Inc. ($2.15M), Vanguard Group Inc. ($1.13M), State Street Corp ($0.79M), Morgan Stanley ($0.25M), Nisa Investment Advisors LLC ($0.21M), Geode Capital Management LLC ($0.20M), and Goldman Sachs Group Inc. ($0.11M).Learn more on ATXI's institutional investors.

What percentage of Avenue Therapeutics stock is owned by institutional investors?

10.87% of Avenue Therapeutics stock is owned by institutional investors. Learn more on ATXI's institutional investor holdings.

Which institutional investors have been buying Avenue Therapeutics stock?

Of the 21 institutional investors that purchased Avenue Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($0.20M), Virtu Financial LLC ($0.10M), National Asset Management Inc. ($65.59K), BlackRock Inc. ($42.32K), Advisory Services Network LLC ($35.12K), Ergoteles LLC ($30.40K), and Kestra Advisory Services LLC ($22.50K).

How much institutional buying is happening at Avenue Therapeutics?

Institutional investors have bought a total of 668,756 shares in the last 24 months. This purchase volume represents approximately $40.87M in transactions.

Which Avenue Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Avenue Therapeutics stock in the last 24 months: Vanguard Group Inc. ($0.25M), National Asset Management Inc. ($99.15K), Northern Trust Corp ($68.92K), Geode Capital Management LLC ($53.04K), Parametric Portfolio Associates LLC ($15.31K), and Wells Fargo & Company MN ($2.50K).

How much institutional selling is happening at Avenue Therapeutics?

Institutional investors have sold a total of 487,075 shares in the last 24 months. This volume of shares sold represents approximately $17.78M in transactions.

This page (NASDAQ:ATXI) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.